Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer

NCT03828799 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

COMBINATION_PRODUCT: Folfirinox + regorafenib

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle